Friday | Jan 10 2025 |
The funding will drive the company’s expansion into diverse therapeutic areas such as in-vitro diagnostics and laboratory solutions through a blend of strategic acquisitions and in-house product development
Subscribe to our newsletter to get updates on our latest news
